Related Experiment Video
Updated: Feb 5, 2026

Direct Drug Delivery to Kidney via the Renal Artery
Published on: April 17, 2021
Urinary kidney injury molecule-1 in renal disease
Rafael N Moresco1, Guilherme V Bochi2, Carolina S Stein1
1Laboratory of Clinical Biochemistry, Department of Clinical and Toxicological Analysis, Federal University of Santa Maria, Santa Maria, RS, Brazil.
Insights
Kidney injury molecule-1 (KIM-1) is a promising biomarker for detecting tubular injury in kidney diseases. Elevated urinary KIM-1 levels correlate with disease severity, offering a sensitive alternative to current markers.
Area of Science:
- Nephrology
- Biomarker Discovery
- Molecular Biology
Background:
- Kidney injury molecule-1 (KIM-1) is a transmembrane glycoprotein implicated in renal tubular injury.
- Current biomarkers like serum creatinine and urinary albumin have limitations in early renal function assessment.
- Tubular injury often precedes glomerular damage in kidney disease pathogenesis.
Purpose of the Study:
- To review the physiological mechanisms of KIM-1.
- To present clinical evidence linking urinary KIM-1 to major renal diseases.
- To highlight KIM-1 as a potential non-invasive biomarker for early detection.
Main Methods:
- Literature review of physiological mechanisms of KIM-1.
- Synthesis of clinical studies investigating urinary KIM-1 levels.
- Analysis of associations between KIM-1 and various kidney diseases.
Main Results:
- Urinary KIM-1 levels rise rapidly following tubular injury.
- KIM-1 levels correlate with the extent of tubular injury, fibrosis, and inflammation.
- Elevated KIM-1 is associated with chronic kidney disease, diabetic kidney disease, acute kidney injury, and IgA nephropathy.
Conclusions:
- KIM-1 is a sensitive and specific biomarker for tubular injury.
- Urinary KIM-1 offers advantages over traditional biomarkers for early disease detection.
- Further research into KIM-1's clinical utility in nephrology is warranted.
Abstract:
Kidney injury molecule-1 (KIM-1), a type l transmembrane glycoprotein, is recognized as a potential biomarker for detection of tubular injury in the main renal diseases. Urinary KIM-1 increases rapidly upon the tubular injury, and its levels are associated with the degree of tubular injury, interstitial fibrosis, and inflammation in the injured kidney. Currently, the investigation of kidney diseases is usually performed through the assessment of serum creatinine and urinary albumin. However, these biomarkers are limited for the early detection of changes in renal function. Besides, the tubular injury appears to precede glomerular damage in the pathophysiology of renal diseases. For these reasons, the search for sensitive, specific and non-invasive biomarkers is of interest. Therefore, the purpose of this article is to review the physiological mechanisms of KIM-1, as well to present clinical evidence about the association between elevated urinary KIM-1 levels and the main renal diseases such as chronic kidney disease, diabetic kidney disease, acute kidney injury, and IgA nephropathy.
Related Concept Videos
Kidney Structure
Acute Kidney Injury I: Introduction
Acute Kidney Injury II: Pathophysiology
Chronic Kidney Disease I: Introduction
Acute Kidney Injury V: Interprofessional Care
Acute Kidney Injury VI: Nursing Management

